Pharma

Promising results from a recent study indicate that tofacitinib, a medication often used for various autoimmune conditions, presents significant improvements in quality of life...

Today marks a significant milestone in the treatment of systemic lupus erythematosus (SLE). Roche has unveiled results from their highly anticipated phase III ALLEGORY...

Navigating the complexities of pediatric drug prescriptions, a recent study highlights the concerning trends of inappropriate medication use among young patients in Brazil. As...

In a pivotal move impacting breast cancer treatment in New Zealand, Pharmac announces a shift in the funded brand of fulvestrant injection. From December...

October witnessed remarkable strides in health innovation across Catalonia, characterized by cutting-edge research breakthroughs, strategic investments, and significant technological advancements. This month showcased a...

Surging into the third quarter of 2025, Apellis Pharmaceuticals showcased remarkable financial momentum. Driving significant revenue growth, the company highlighted its strong product performance,...

In Vietnam, tackling the complexity of healthcare among elderly patients with Type 2 Diabetes Mellitus (T2DM) has always posed significant challenges due to the...

Zai Lab released promising data from their Phase 1 trial of zocilurtatug pelitecan (formerly ZL-1310), marking a significant advancement in small cell lung cancer...

As bacterial resistance to antibiotics spirals, the need for alternative therapies becomes paramount. Bacteriophage, or phage therapy, surfaces as a promising prospect aimed at...

At the upcoming Liver Meeting® 2025 in Washington, D.C., Gilead Sciences, Inc., plans to unveil a series of pivotal research findings aimed at advancing...

Every household in New Zealand, like many communities globally, likely contains a supply of paracetamol, a go-to remedy for pain relief owing to its...

A recent agreement between pharmaceutical giant GSK and biotech innovator Syndivia has unveiled a promising new chapter in prostate cancer treatment. Cementing GSK's strategic...

Global pharmaceutical giant F. Hoffmann-La Roche Ltd. has reported its financial performance for the third quarter of 2025, showcasing a growth trajectory amid evolving...

Medication often serves as the bastion of hope for patients undergoing organ transplants. Mycophenolate mofetil Teva, a generic alternative of the medicine CellCept, plays...

In the heart of rural Uganda, where healthcare accessibility remains a challenge, a revolutionary mobile intervention, Call For Life - Interactive Voice Response (C4L-IVR),...